H

Hemagen Diagnostics Inc
OTC:HMGN

Watchlist Manager
Hemagen Diagnostics Inc
OTC:HMGN
Watchlist
Price: 0.0016 USD Market Closed
Market Cap: $24.8k

Hemagen Diagnostics Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Hemagen Diagnostics Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
H
Hemagen Diagnostics Inc
OTC:HMGN
Research & Development
-$44.7k
CAGR 3-Years
21%
CAGR 5-Years
-10%
CAGR 10-Years
20%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$2.1B
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Stryker Corp
NYSE:SYK
Research & Development
-$1.6B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.9B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
IDEXX Laboratories Inc
NASDAQ:IDXX
Research & Development
-$251.2m
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
-10%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.3B
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-21%
No Stocks Found

Hemagen Diagnostics Inc
Glance View

Market Cap
24.8k USD
Industry
Health Care

Hemagen Diagnostics, Inc. is a biotechnology company. The company is headquartered in Columbia, Maryland and currently employs 15 full-time employees. The firm is primarily focused on Veterinary Clinical Diagnostics. The company is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. The firm develops, manufactures and markets a range of test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. The Company’s autoimmune product portfolio includes Hemagen DNA Kit, Hemagen Rheumatoid Factor Kit, VIRGO AMA IgG, VIRGO ANA/Hep-2 IgG, VIRGO Anti-nDNA IgG, VIRGO cANCA (PR-3) Kit, VIRGO dsDNA Kit, VIRGO ENA Screen 6 Kit, VIRGO ENA Screening, VIRGO ENA Series, VIRGO pANCA myeloperoxidase (MPO) Kit and VIRGO Rheumatoid Factor Kit. The company offers various products for infectious disease, which includes VIRGO C. trach IgG, VIRGO CMV IgG and VIRGO epstein-barr virus (EBV)- viral capsid antigen (VCA) IgG. Its products are used in laboratories, hospitals and blood banks around the world.

HMGN Intrinsic Value
Not Available
H

See Also

What is Hemagen Diagnostics Inc's Research & Development?
Research & Development
-44.7k USD

Based on the financial report for Sep 30, 2012, Hemagen Diagnostics Inc's Research & Development amounts to -44.7k USD.

What is Hemagen Diagnostics Inc's Research & Development growth rate?
Research & Development CAGR 10Y
20%

Over the last year, the Research & Development growth was -794%. The average annual Research & Development growth rates for Hemagen Diagnostics Inc have been 21% over the past three years , -10% over the past five years , and 20% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett